NCT04129112View on ClinicalTrials.gov

Evaluation of Influencing Variables in Awakening Concentration and Concentration at Body Movements of Propofol TCI (Targeted Controlled Infusion) Targeted at the Effector Site

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions
Awareness, Anesthesia
Interventions
DRUG

We do not modify the normale general anesthesia delivery. We note the concentration of propofol at the effector site of body movementsand awakening

Propofol in our hospital is routinely delivered by Targeted Controlled Infusion (TCI) pumps. We note the concentration of propofol at the effector site of body movements and awakening

Trial Locations (1)

31100

ULSS 2 Marca Trevigiana, Treviso

All Listed Sponsors
lead

University of Padova

OTHER

NCT04129112 - Evaluation of Influencing Variables in Awakening Concentration and Concentration at Body Movements of Propofol TCI (Targeted Controlled Infusion) Targeted at the Effector Site | Biotech Hunter | Biotech Hunter